SAM #75N98026Q00356

NIH Molecular Diagnostics Testing Using QX200 ddPCR Instrument

The National Institutes of Health (NIH), Office of Acquisition and Logistics Management, is seeking clinical laboratory molecular diagnostics testing using the QX200 ddPCR instrument to support cancer diagnosis and personalized therapies in the Lab of Pathology, CCR. - Government Buyer: - National Institutes of Health (NIH), Office of the Director (OD), Office of Acquisition and Logistics Management (OALM) - OEMs and Vendors: - QX200 ddPCR instrument (OEM: Bio-Rad Laboratories, Inc.) - Nexus Group LLC (intended awardee for services) - Products/Services Requested: - Clinical Laboratory Molecular Diagnostics Test using QX200 ddPCR instrument - Supports molecular oncology testing for cancer diagnosis, prognosis prediction, and identification of targets for personalized therapies - No specific part numbers or quantities disclosed - Notable Requirements: - Testing must utilize the QX200 ddPCR instrument platform - Supports advanced molecular oncology applications for NIH's Lab of Pathology - Non-competitive procurement under NAICS code 334516 - Estimated contract value not to exceed $350,000

Description

Attachment; Notice of Intent

View original listing